feed,title,long_url,short_url
Benzinga,This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics' Prospects After FDA Agreement Despite Investor Concerns,https://benzinga.com/general/biotech/23/11/35596429/this-analyst-upgrades-vision-disorder-focused-outlook-therapeutics-prospects-after-fda-agreement-,https://da.gd/5vCfB0
